MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040)

NCT00289848 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

530

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: sitagliptin phosphate
DRUG: Comparator: placebo

Sponsor

Merck Sharp & Dohme LLC